The pharmaceutical sector is navigating a challenging landscape, marked by rising raw material costs and significant supply chain disruptions. As these factors tighten profit margins, pharmaceutical companies are under increasing pressure, particularly from regulatory bodies in the US, to reduce drug prices. This financial strain is compounded by a wave of expiring patents, which threatens to intensify competition and disrupt market stability. In response to these challenges, the integration of agentic AI is emerging as a transformative force within the industry. By leveraging advanced artificial intelligence, pharma companies can enhance operational efficiency, optimize research and development processes, and ultimately improve patient outcomes. This innovative technology not only aids in cost management but also accelerates the drug discovery process, paving the way for new treatments. As the industry adapts to these changes, agentic AI stands poised to redefine the future of pharmaceuticals, providing a path toward sustainability and improved health solutions in a rapidly evolving market.